{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:19:54Z","timestamp":1787015994946,"version":"build-2736575974"},"reference-count":79,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":260,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast J"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1111\/tbj.12361","type":"journal-article","created":{"date-parts":[[2014,12,15]],"date-time":"2014-12-15T00:25:22Z","timestamp":1418603122000},"page":"3-12","source":"Crossref","is-referenced-by-count":80,"title":["Milestones in Breast Cancer Treatment"],"prefix":"10.1155","volume":"21","author":[{"given":"Stefano","family":"Zurrida","sequence":"first","affiliation":[{"name":"European Institute of Oncology; Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Veronesi","sequence":"additional","affiliation":[{"name":"European Institute of Oncology; Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,12,15]]},"reference":[{"key":"10.1111\/tbj.12361-BIB0001|tbj12361-cit-0001","volume-title":"The Edwin Smith Surgical Papyrus. Translation for The New York Historical Society","author":"Breasted","year":"1930"},{"key":"10.1111\/tbj.12361-BIB0002|tbj12361-cit-0002","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1056\/NEJM198107023050102","article-title":"Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast","volume":"305","author":"Veronesi","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1111\/tbj.12361-BIB0003|tbj12361-cit-0003","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0277-5379(90)90114-9","article-title":"Quadrantectomy versus lumpectomy for small size breast cancer","volume":"26","author":"Veronesi","year":"1990","journal-title":"Eur J Cancer"},{"key":"10.1111\/tbj.12361-BIB0004|tbj12361-cit-0004","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1056\/NEJM199306033282202","article-title":"Radiotherapy after breast-preserving surgery in women with localized cancer of the breast","volume":"328","author":"Veronesi","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1111\/tbj.12361-BIB0005|tbj12361-cit-0005","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa020989","article-title":"Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer","volume":"347","author":"Veronesi","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/tbj.12361-BIB0006|tbj12361-cit-0006","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1056\/NEJM198503143121101","article-title":"Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer","volume":"312","author":"Fisher","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1111\/tbj.12361-BIB0007|tbj12361-cit-0007","unstructured":"Treatment of Early-Stage Breast Cancer. NIH Consensus Statement http:\/\/consensus.nih.gov\/1990\/1990earlystagebreastcancer081html.html"},{"key":"10.1111\/tbj.12361-BIB0008|tbj12361-cit-0008","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1200\/JCO.2008.17.9234","article-title":"Trends in racial and age disparities in definitive local therapy of early-stage breast cancer","volume":"27","author":"Freedman","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1111\/tbj.12361-BIB0009|tbj12361-cit-0009","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.ejca.2012.03.008","article-title":"Mastectomy trends for early-stage breast cancer: a report from the EUSOMA multi-institutional European database","volume":"48","author":"Garcia-Etienne","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1111\/tbj.12361-BIB0010|tbj12361-cit-0010","first-page":"127","article-title":"Extent of metastatic axillary involvement in 1446 cases of breast cancer","volume":"16","author":"Veronesi","year":"1990","journal-title":"Eur J Surg Oncol"},{"issue":"6 Suppl","key":"10.1111\/tbj.12361-BIB0011|tbj12361-cit-0011","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1002\/1097-0142(197706)39:6<2827::AID-CNCR2820390671>3.0.CO;2-I","article-title":"Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trial","volume":"39","author":"Fisher","year":"1977","journal-title":"Cancer"},{"key":"10.1111\/tbj.12361-BIB0012|tbj12361-cit-0012","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/cncr.10983","article-title":"Sequelae of axillary lymph node dissection in older women with stage 1 and 2 breast carcinoma","volume":"95","author":"Mandelblatt","year":"2002","journal-title":"Cancer"},{"key":"10.1111\/tbj.12361-BIB0013|tbj12361-cit-0013","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1023\/A:1026564723698","article-title":"Long-term morbidity following axillary dissection in breast cancer patients-clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors","volume":"64","author":"Kuehn","year":"2000","journal-title":"Breast Cancer Res Treat"},{"key":"10.1111\/tbj.12361-BIB0014|tbj12361-cit-0014","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0960-7404(93)90064-6","article-title":"Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe","volume":"2","author":"Krag","year":"1993","journal-title":"Surg Oncol"},{"key":"10.1111\/tbj.12361-BIB0015|tbj12361-cit-0015","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00000658-199509000-00016","article-title":"Improved axillary staging of breast cancer with sentinel lymphadenectomy","volume":"222","author":"Giuliano","year":"1995","journal-title":"Ann Surg"},{"key":"10.1111\/tbj.12361-BIB0016|tbj12361-cit-0016","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa012782","article-title":"A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer","volume":"349","author":"Veronesi","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1111\/tbj.12361-BIB0017|tbj12361-cit-0017","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/SLA.0b013e3181c0e92a","article-title":"Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study","volume":"251","author":"Veronesi","year":"2010","journal-title":"Ann Surg"},{"key":"10.1111\/tbj.12361-BIB0018|tbj12361-cit-0018","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1200\/JCO.2013.54.1177","article-title":"Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update","volume":"32","author":"Lyman","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1111\/tbj.12361-BIB0019|tbj12361-cit-0019","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1470-2045(13)70035-4","article-title":"Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial","volume":"14","author":"Galimberti","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1111\/tbj.12361-BIB0020|tbj12361-cit-0020","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"key":"10.1111\/tbj.12361-BIB0021|tbj12361-cit-0021","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s10585-012-9515-z","article-title":"Should ACOSOG Z0011 change practice with respect to axillary lymph node dissection for a positive sentinel lymph node biopsy in breast cancer?","volume":"29","author":"Giuliano","year":"2012","journal-title":"Clin Exp Metastasis"},{"key":"10.1111\/tbj.12361-BIB0022|tbj12361-cit-0022","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.breast.2012.06.013","article-title":"Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: sentinel node vs observation after axillary UltraSouND)","volume":"21","author":"Gentilini","year":"2012","journal-title":"Breast"},{"key":"10.1111\/tbj.12361-BIB0023|tbj12361-cit-0023","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1634\/theoncologist.2010-0123","article-title":"Nonpalpable breast carcinomas: long-term evaluation of 1,258 cases","volume":"15","author":"Veronesi","year":"2010","journal-title":"Oncologist"},{"key":"10.1111\/tbj.12361-BIB0024|tbj12361-cit-0024","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2217\/whe.11.73","article-title":"Mammographic screening: keeping women alive","volume":"7","author":"Verbeek","year":"2011","journal-title":"Womens Health (Lond Engl)"},{"key":"10.1111\/tbj.12361-BIB0025|tbj12361-cit-0025","unstructured":"http:\/\/globocan.iarc.fr\/Pages\/fact_sheets_cancer.aspx"},{"key":"10.1111\/tbj.12361-BIB0026|tbj12361-cit-0026","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1007\/s00330-010-1844-1","article-title":"Breast cancer detection: radiologists' performance using mammography with and without automated whole-breast ultrasound","volume":"20","author":"Kelly","year":"2010","journal-title":"Eur Radiol"},{"key":"10.1111\/tbj.12361-BIB0027|tbj12361-cit-0027","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.breast.2005.04.002","article-title":"Occult breast lesions: a comparison between radioguided occult lesion localisation (ROLL) vs. wire-guided lumpectomy (WGL)","volume":"14","author":"Nadeem","year":"2005","journal-title":"Breast"},{"key":"10.1111\/tbj.12361-BIB0028|tbj12361-cit-0028","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1046\/j.1365-2168.1999.01078.x","article-title":"Comparison of radioguided excision with wire localization of occult breast lesions","volume":"86","author":"Luini","year":"1999","journal-title":"Br J Surg"},{"key":"10.1111\/tbj.12361-BIB0029|tbj12361-cit-0029","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1245\/s10434-007-9452-2","article-title":"Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology","volume":"14","author":"Monti","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1111\/tbj.12361-BIB0030|tbj12361-cit-0030","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejso.2011.12.003","article-title":"Radioguided occult lesion localization plus sentinel node biopsy (SNOLL) versus wire-guided localization plus sentinel node detection: a case control study of 129 unifocal pure invasive non-palpable breast cancer","volume":"38","author":"Giacalone","year":"2012","journal-title":"Eur J Surg Oncol"},{"key":"10.1111\/tbj.12361-BIB0031|tbj12361-cit-0031","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1001\/jama.2009.1450","article-title":"Surgeon recommendations and receipt of mastectomy for treatment of breast cancer","volume":"302","author":"Morrow","year":"2009","journal-title":"JAMA"},{"issue":"Suppl 3","key":"10.1111\/tbj.12361-BIB0032|tbj12361-cit-0032","first-page":"378","article-title":"Oncologic safety of nipple skin-sparing or total skin-sparing mastectomies with immediate reconstruction","volume":"17","author":"Boneti","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1111\/tbj.12361-BIB0033|tbj12361-cit-0033","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/cncr.25505","article-title":"Local, regional and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomy","volume":"117","author":"Yi","year":"2011","journal-title":"Cancer"},{"key":"10.1111\/tbj.12361-BIB0034|tbj12361-cit-0034","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10549-008-9891-x","article-title":"Oncological results of immediate breast reconstruction: long term follow-up of a large series at a single institution","volume":"112","author":"Petit","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1111\/tbj.12361-BIB0035|tbj12361-cit-0035","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10549-010-0951-7","article-title":"New concept for immediate breast reconstruction for invasive cancers: feasibility, oncological safety and esthetic outcome of post-neoadjuvant therapy immediate breast reconstruction versus delayed breast reconstruction: a prospective pilot study","volume":"122","author":"Giacalone","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1111\/tbj.12361-BIB0036|tbj12361-cit-0036","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10549-008-0304-y","article-title":"Nipple sparing mastectomy with nipple areola intraoperative radiotherapy: one thousand and one cases of a five years experience at European Institute of Oncology of Milan (EIO)","volume":"117","author":"Petit","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1111\/tbj.12361-BIB0037|tbj12361-cit-0037","doi-asserted-by":"crossref","unstructured":"Early Breast Cancer Trialists' Collaborative Group (EBCTCG) Darby S McGale P Correa C et\u00a0al Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials 2011 378 1707 16","DOI":"10.1016\/S0140-6736(11)61629-2"},{"key":"10.1111\/tbj.12361-BIB0038|tbj12361-cit-0038","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0140-6736(08)60348-7","article-title":"The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial","volume":"371","author":"Bentzen","year":"2008","journal-title":"Lancet"},{"key":"10.1111\/tbj.12361-BIB0039|tbj12361-cit-0039","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/tbj.12361-BIB0040|tbj12361-cit-0040","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nrc2288","article-title":"Innovations in image-guided radiotherapy","volume":"7","author":"Verellen","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1111\/tbj.12361-BIB0041|tbj12361-cit-0041","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ijrobp.2010.10.068","article-title":"Randomized controlled trial of forward-planned intensity-modulated radiotherapy for early breast cancer: interim results at 2 years","volume":"82","author":"Barnett","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1111\/tbj.12361-BIB0042|tbj12361-cit-0042","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.radonc.2006.12.008","article-title":"Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy","volume":"82","author":"Donovan","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1111\/tbj.12361-BIB0043|tbj12361-cit-0043","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1200\/JCO.2007.15.2488","article-title":"A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis","volume":"26","author":"Pignol","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1111\/tbj.12361-BIB0044|tbj12361-cit-0044","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/jnci\/djr100","article-title":"Adoption of intensity-modulated radiation therapy for breast cancer in the United States","volume":"103","author":"Smith","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/tbj.12361-BIB0045|tbj12361-cit-0045","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1023\/A:1011136326943","article-title":"Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial","volume":"12","author":"Veronesi","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1111\/tbj.12361-BIB0046|tbj12361-cit-0046","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/bjc.1996.442","article-title":"Multicentricity of breast cancer: whole-organ analysis and clinical implications","volume":"74","author":"Vaidya","year":"1996","journal-title":"Br J Cancer"},{"key":"10.1111\/tbj.12361-BIB0047|tbj12361-cit-0047","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10549-010-1115-5","article-title":"Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons","volume":"124","author":"Veronesi","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1111\/tbj.12361-BIB0048|tbj12361-cit-0048","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S1470-2045(13)70497-2","article-title":"Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial","volume":"14","author":"Veronesi","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1111\/tbj.12361-BIB0049|tbj12361-cit-0049","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJMoa010874","article-title":"Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation","volume":"345","author":"Bartelink","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/tbj.12361-BIB0050|tbj12361-cit-0050","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00066-002-1053-1","article-title":"Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage l-ll breast cancer first results of the randomized Budapest boost trial","volume":"178","author":"Polgar","year":"2002","journal-title":"Stralenther Onkol"},{"key":"10.1111\/tbj.12361-BIB0051|tbj12361-cit-0051","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1200\/JCO.1997.15.3.963","article-title":"Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France","volume":"15","author":"Romestaing","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1111\/tbj.12361-BIB0052|tbj12361-cit-0052","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.radonc.2013.05.031","article-title":"IORT with electrons as boost strategy during breast conserving therapy in limited stage\u00a0breast cancer: long term results of an ISIORT pooled analysis","volume":"108","author":"Fastner","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1111\/tbj.12361-BIB0053|tbj12361-cit-0053","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ijrobp.2007.12.038","article-title":"Preliminary results of electron intraoperative therapy boost and hypofractionated external beam radiotherapy after breast-conserving surgery in premenopausal women","volume":"72","author":"Ivaldi","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1111\/tbj.12361-BIB0054|tbj12361-cit-0054","unstructured":"http:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01343459?term=hiob&rank=1"},{"key":"10.1111\/tbj.12361-BIB0055|tbj12361-cit-0055","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/bjc.1971.33","article-title":"A new anti-estrogenic agent in late breast cancer. An early clinical appraisal of ICI46474","volume":"25","author":"Cole","year":"1971","journal-title":"Br J Cancer"},{"key":"10.1111\/tbj.12361-BIB0056|tbj12361-cit-0056","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0140-6736(83)90406-3","article-title":"Improved survival among patients treated with adjuvant tamoxifen after mastectomy for early breast cancer","volume":"2","author":"Baum","year":"1983","journal-title":"Lancet"},{"key":"10.1111\/tbj.12361-BIB0057|tbj12361-cit-0057","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0163-7258(84)90043-3","article-title":"The pharmacology and clinical uses of tamoxifen","volume":"25","author":"Furr","year":"1984","journal-title":"Pharmacol Ther"},{"key":"10.1111\/tbj.12361-BIB0058|tbj12361-cit-0058","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0140-6736(97)11423-4","article-title":"Tamoxifen for early breast cancer: an overview of the randomized trials","volume":"351","author":"Early Breast Cancer Trialists Collaborative Group","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/tbj.12361-BIB0059|tbj12361-cit-0059","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1200\/JCO.2013.54.2258","article-title":"Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American Society of Clinical Oncology clinical practice guideline focused update","volume":"32","author":"Burstein","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1111\/tbj.12361-BIB0060|tbj12361-cit-0060","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1404037","article-title":"Adjuvant exemestane with ovarian suppression in premenopausal breast cancer","volume":"371","author":"Pagani","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1111\/tbj.12361-BIB0061|tbj12361-cit-0061","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrd1031","article-title":"Tamoxifen: a most unlikely pioneering medicine","volume":"2","author":"Jordan","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1111\/tbj.12361-BIB0062|tbj12361-cit-0062","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1158\/1940-6207.CAPR-10-0076","article-title":"Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer","volume":"3","author":"Vogel","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1111\/tbj.12361-BIB0063|tbj12361-cit-0063","doi-asserted-by":"crossref","first-page":"8643","DOI":"10.1158\/0008-5472.CAN-07-6611","article-title":"A history of cancer chemotherapy","volume":"68","author":"DeVita","year":"2008","journal-title":"Cancer Res"},{"key":"10.1111\/tbj.12361-BIB0064|tbj12361-cit-0064","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1136\/bmj.282.6274.1427","article-title":"Multimodal treatment in operable breast cancer: five-year results of the CMF programme","volume":"282","author":"Rossi","year":"1981","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1111\/tbj.12361-BIB0065|tbj12361-cit-0065","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01655184","article-title":"Adjuvant CMF chemotherapy in operable breast cancer: ten years later","volume":"9","author":"Bonadonna","year":"1985","journal-title":"World J Surg"},{"issue":"1","key":"10.1111\/tbj.12361-BIB0066|tbj12361-cit-0066","first-page":"CD000487","article-title":"Multi-agent chemotherapy for early breast cancer","author":"Early Breast Cancer Trialists' Collaborative Group","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1111\/tbj.12361-BIB0067|tbj12361-cit-0067","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2174\/157340311799960645","article-title":"Anthracycline cardiotoxicity: prevalence, pathogenesis and treatment","volume":"7","author":"Volkova","year":"2011","journal-title":"Curr Cardiol Rev"},{"key":"10.1111\/tbj.12361-BIB0068|tbj12361-cit-0068","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0140-6736(98)03301-7","article-title":"Polychemotherapy for early breast cancer: an overview of the randomized trials","volume":"352","author":"Early Breast Cancer Trialists' Collaborative Group","year":"1998","journal-title":"Lancet"},{"key":"10.1111\/tbj.12361-BIB0069|tbj12361-cit-0069","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","article-title":"Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013","volume":"24","author":"Goldhirsch","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1111\/tbj.12361-BIB0070|tbj12361-cit-0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1158\/2159-8290.CD-12-0462","article-title":"The genomic landscape of breast cancer as a therapeutic roadmap","volume":"3","author":"Ellis","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1111\/tbj.12361-BIB0071|tbj12361-cit-0071","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/stem.160413","article-title":"The HER-2\/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy","volume":"16","author":"Ross","year":"1998","journal-title":"Stem Cells"},{"key":"10.1111\/tbj.12361-BIB0072|tbj12361-cit-0072","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0910383","article-title":"Adjuvant trastuzumab in HER2-positive breast cancer","volume":"365","author":"Slamon","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/tbj.12361-BIB0073|tbj12361-cit-0073","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1056\/NEJMoa052306","article-title":"Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer","volume":"353","author":"Piccart-Gebhart","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/tbj.12361-BIB0074|tbj12361-cit-0074","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S1470-2045(13)70225-0","article-title":"6\u00a0months versus 12\u00a0months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial","volume":"14","author":"Pivot","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1111\/tbj.12361-BIB0075|tbj12361-cit-0075","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa1113216","article-title":"Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer","volume":"366","author":"Baselga","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1111\/tbj.12361-BIB0076|tbj12361-cit-0076","article-title":"Final overall survival (OS) analysis from the CLEOPATRA study of first-line (1L) pertuzumab (Ptz), trastuzumab (T), and docetaxel (D) in patients (pts) with HER2-positive metastatic breast cancer (MBC)","author":"Swain","year":"2014","journal-title":"European Society for Medical Oncology"},{"key":"10.1111\/tbj.12361-BIB0077|tbj12361-cit-0077","unstructured":"http:\/\/www.onclive.com\/publications\/oncology-business-news\/2012\/November-2012\/Treatment-and-Cost-Implications-of-Pertuzumab"},{"key":"10.1111\/tbj.12361-BIB0078|tbj12361-cit-0078","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1245\/s10434-009-0635-x","article-title":"Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients","volume":"16","author":"McGuire","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1111\/tbj.12361-BIB0079|tbj12361-cit-0079","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1245\/s10434-012-2732-5","article-title":"Increasing national mastectomy rates for the treatment of early stage breast cancer","volume":"20","author":"Mahmood","year":"2013","journal-title":"Ann Surg Oncol"}],"container-title":["The Breast Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftbj.12361","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/tbj.12361\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T01:27:30Z","timestamp":1643333250000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tbj.12361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,15]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"URL":"https:\/\/doi.org\/10.1111\/tbj.12361","relation":{},"ISSN":["1075-122X"],"issn-type":[{"value":"1075-122X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12,15]]}}}